Jul 2 |
AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use
|
Jul 2 |
EMA fast-tracks review of AstraZeneca’s sipavibart to stop Covid
|
Jul 1 |
AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment
|
Jul 1 |
AstraZeneca COVID prevention antibody gets EU fast-track review
|
Jul 1 |
Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
|
Jun 28 |
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
|
Jun 26 |
7 Biotech Stocks to Boost Your Portfolio to Peak Health
|
Jun 26 |
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
|
Jun 26 |
Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst
|
Jun 26 |
China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer Patients
|